Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Cash from Financing Activities (2020 - 2025)

Caribou Biosciences has reported Cash from Financing Activities over the past 6 years, most recently at $4.1 million for Q4 2025.

  • Quarterly Cash from Financing Activities rose 5.36% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2025, down 71.17% year-over-year, with the annual reading at $4.8 million for FY2025, 71.17% down from the prior year.
  • Cash from Financing Activities was $4.1 million for Q4 2025 at Caribou Biosciences, up from $277000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $322.7 million in Q3 2021 and troughed at -$43000.0 in Q4 2023.
  • The 5-year median for Cash from Financing Activities is $630000.0 (2021), against an average of $30.6 million.
  • Year-over-year, Cash from Financing Activities skyrocketed 288009.82% in 2021 and then crashed 133.86% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $460000.0 in 2021, then plummeted by 72.39% to $127000.0 in 2022, then plummeted by 133.86% to -$43000.0 in 2023, then surged by 9083.72% to $3.9 million in 2024, then grew by 5.36% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Cash from Financing Activities are $4.1 million (Q4 2025), $277000.0 (Q3 2025), and $6000.0 (Q2 2025).